Chris Bertolino, MBA, is an award-winning biotechnology leader currently serving as the U.S. Brand Lead for the Denosumab Biosimilar Launch at Sandoz since 2023. With a proven track record in commercial excellence, Chris has successfully executed marketing strategies and product launches across various pharmaceutical companies, including Amgen and Wyeth Pharmaceuticals. They hold an MBA in Pharmaceutical and Healthcare Marketing and a Bachelor's degree in Pharmaceutical Marketing from Saint Joseph's University, further enhancing their commitment to empathetic leadership and a people-first approach in the workplace.
This person is not in the org chart
This person is not in any teams
This person is not in any offices